Tag: treatment and recovery

  • Canadian Drug Policy Coalition/ Doalition canadienne des politiques sur les drogues

    Unions Can Take a Stand on Drug Policy

    Bad drug policy hurts workers. You’d be hard-pressed to find somebody in this country whose community hasn’t been affected by the drug poisoning crisis.

    That’s why it’s so important when labour unions take a stand on drug policy.

    There’s momentum building in the labour movement to protect workers and their communities from the unregulated drug supply that causes so much harm. In the last year, we’ve seen unions pass unanimous and near-unanimous resolutions at conventions declaring their support for safe supply, decrying involuntary treatment and demanding regulation for the treatment industry. 

    We would like to thank these unions for their leadership, passing resolutions on drug policy:

    If you’re a union member and your union isn’t on this list, you can organize your fellow workers. Reach out to [email protected] for more information.

    For more than a hundred years, the labour movement has been a driving force for social and economic change in this country. Whether it be childcare, healthcare, workplace safety or environmental protection, with the strength of hundreds of thousands of members, union power can propel massive shifts toward more equitable, safer communities. Labour and organized workers can play a key role in work to end the drug war and reinvest in our communities.

    Together we say: No More Drug War on the Shop Floor!

  • Medications and clinical approaches to support physical distancing for PWUD

    Medications and clinical approaches to support physical distancing for PWUD

    physical distancing for people who use drugs, physical distancing for people who use drugs


    Click HERE for more resources

    “This document is one in a series of six national guidance documents, developed rapidly by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, a significant number of works were consulted in drafting this guidance; a list of works consulted is provided in Appendix 1: Works Consulted on page 31.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Reducing COVID-19 Spread in Recovery Programs & Treatment Services

    Reducing COVID-19 Spread in Recovery Programs & Treatment Services

    reducing COVID-19 transmission in recovery and treatment programs, reducing COVID-19 transmission in recovery and treatment programs


    Click HERE for more resources

    “This document is one in a series of six national guidance documents, developed rapidly by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Telemedicine support for addiction services

    Telemedicine support for addiction services

    telemedicine support for addiction services, telemedicine support for addiction services


    Click HERE for more resources

    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM